| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 700455 | Quinoline-3,3,4,4-tetracarbonitrile, 2-(4-bromophenyl)-1,2,3,4,5,6,7,8-octahydro- | 0.0385613993886001 | 0.79839888 |
| NSC 707904 | Null | 0.0385613993886001 | 0.27860422 |
| NSC 709562 | Null | 0.0385613993886001 | 0.17986608 |
| NSC 714379 | Null | 0.0385613993886001 | 0.51471412 |
| NSC 722854 | 1,4-di-N-oxide-2-phenylcarbonyl-3-trifluoromethylquinoxaline | 0.0385613993886001 | 0.3768898 |
| NSC 723732 | 8-{4-[6-(4-flurophenyl)-2-methyl-4-pyrimidinyloxy]butoxy}-7- methoxy-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a ][1,4]diazepin-5-one | 0.0385613993886001 | 0.35977436 |
| NSC 728035 | 1N-{2-[7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[ e]pyrrolo[1,2-a][1,4]diazepin-8-yloxy]ethyl}-2-[8-benzyloxy- 7-methoxy-5-oxo-(11aS)-2,3,5,11a-tetrahydro-1H-benzo[e]pyrro lo[1,2-a][1,4]di | 0.0385613993886001 | 0.4443687 |
| NSC 728038 | 2[(3,4-dicloro)benzylamino]-3-phenyl-5,7-diamino quinoxaline | 0.0385613993886001 | 0.50136759 |
| NSC 733503 | cis-6-(3-Bromopropyl)-12,13-dihydro-8,9-dimethoxy-3-nitro-5, 11-dioxo-11H-indeno[1,2-c]isoquinoline | 0.0385613993886001 | 0.30038009 |
| NSC 733504 | Everolimus | 0.0385613993886001 | -0.098212348 |